Acelya Yilmazer, PhD - Publications

Affiliations: 
2007-2008 School of Pharmacy University of Nottingham, Nottingham, England, United Kingdom 
 2008-2013 School of Pharmacy University of London, London, England, United Kingdom 
 2013- Engineering Faculty, Biomedical Engineering Department Ankara University 
Area:
liposome, drug delivery, regenerative medicine
Website:
http://yilmazerlab.com/Login/Home

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Kisby T, Yilmazer A, Kostarelos K. Author Correction: Reasons for success and lessons learnt from nanoscale vaccines against COVID-19. Nature Nanotechnology. 17: 671. PMID 35551244 DOI: 10.1038/s41565-022-01141-0  0.697
2021 Kisby T, Yilmazer A, Kostarelos K. Reasons for success and lessons learnt from nanoscale vaccines against COVID-19. Nature Nanotechnology. 16: 843-850. PMID 34381200 DOI: 10.1038/s41565-021-00946-9  0.696
2021 Unal MA, Bayrakdar F, Nazir H, Besbinar O, Gurcan C, Lozano N, Arellano LM, Yalcin S, Panatli O, Celik D, Alkaya D, Agan A, Fusco L, Suzuk Yildiz S, Delogu LG, ... ... Yilmazer A, et al. Graphene Oxide Nanosheets Interact and Interfere with SARS-CoV-2 Surface Proteins and Cell Receptors to Inhibit Infectivity. Small (Weinheim An Der Bergstrasse, Germany). e2101483. PMID 33988903 DOI: 10.1002/smll.202101483  0.705
2020 Weiss C, Carriere M, Fusco L, Capua I, Regla-Nava JA, Pasquali M, Scott JA, Vitale F, Unal MA, Mattevi C, Bedognetti D, Merkoçi A, Tasciotti E, Yilmazer A, Gogotsi Y, et al. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic. Acs Nano. PMID 32519842 DOI: 10.1021/Acsnano.0C03697  0.307
2020 Taheri H, Unal MA, Sevim M, Gurcan C, Ekim O, Ceylan A, Syrgiannis Z, Christoforidis KC, Bosi S, Ozgenç O, Gómez MJ, Turktas Erken M, Soydal Ç, Eroğlu Z, Bitirim CV, ... ... Yilmazer A, et al. Photocatalytically Active Graphitic Carbon Nitride as an Effective and Safe 2D Material for In Vitro and In Vivo Photodynamic Therapy. Small (Weinheim An Der Bergstrasse, Germany). e1904619. PMID 31971659 DOI: 10.1002/Smll.201904619  0.619
2020 Taheri H, Unal MA, Sevim M, Gurcan C, Ekim O, Ceylan A, Syrgiannis Z, Christoforidis KC, Bosi S, Ozgenç O, Gómez MJ, Turktas Erken M, Soydal Ç, Eroğlu Z, Bitirim CV, ... ... Yilmazer A, et al. Photodynamic Therapy: Photocatalytically Active Graphitic Carbon Nitride as an Effective and Safe 2D Material for In Vitro and In Vivo Photodynamic Therapy (Small 10/2020) Small. 16: 2070051. DOI: 10.1002/Smll.202070051  0.604
2020 Lázaro I, Sharp P, Gurcan C, Ceylan A, Stylianou M, Kisby T, Chen Y, Vranic S, Barr K, Taheri H, Ozen A, Bussy C, Yilmazer A, Kostarelos K. Deep Tissue Translocation of Graphene Oxide Sheets in Human Glioblastoma 3D Spheroids and an Orthotopic Xenograft Model Advanced Therapeutics. 4: 2000109. DOI: 10.1002/adtp.202000109  0.413
2019 Gazzi A, Fusco L, Khan A, Bedognetti D, Zavan B, Vitale F, Yilmazer A, Delogu LG. Photodynamic Therapy Based on Graphene and MXene in Cancer Theranostics. Frontiers in Bioengineering and Biotechnology. 7: 295. PMID 31709252 DOI: 10.3389/Fbioe.2019.00295  0.305
2019 Taheri H, Cagin U, Yilmazer A. Reprogramming of Human Melanocytes and Melanoma Cells with Yamanaka Factors. Methods in Molecular Biology (Clifton, N.J.). 1916: 249-261. PMID 30535702 DOI: 10.1007/978-1-4939-8994-2_24  0.621
2018 de Lázaro I, Yilmazer A, Nam Y, Qubisi S, Razak FMA, Degens H, Cossu G, Kostarelos K. Non-viral, Tumor-free Induction of Transient Cell Reprogramming in Mouse Skeletal Muscle to Enhance Tissue Regeneration. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30470628 DOI: 10.1016/J.Ymthe.2018.10.014  0.678
2018 Aydin T, Gurcan C, Taheri H, Yilmazer A. Graphene Based Materials in Neural Tissue Regeneration. Advances in Experimental Medicine and Biology. PMID 29882208 DOI: 10.1007/5584_2018_221  0.607
2018 Yilmazer A. Cancer cell lines involving cancer stem cell populations respond to oxidative stress. Biotechnology Reports (Amsterdam, Netherlands). 17: 24-30. PMID 29276697 DOI: 10.1016/J.Btre.2017.11.004  0.302
2016 Teralı K, Yilmazer A. New surprises from an old favourite: The emergence of telomerase as a key player in the regulation of cancer stemness. Biochimie. 121: 170-8. PMID 26700144 DOI: 10.1016/J.Biochi.2015.12.001  0.314
2015 Yilmazer A, de Lázaro I, Taheri H. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling? Cancer Letters. 369: 1-8. PMID 26276716 DOI: 10.1016/J.Canlet.2015.06.027  0.609
2014 Yilmazer A, Tian B, Kostarelos K. Development of dual-activity vectors by co-envelopment of adenovirus and SiRNA in artificial lipid bilayers. Plos One. 9: e114985. PMID 25501573 DOI: 10.1371/Journal.Pone.0114985  0.54
2014 de Lázaro I, Bussy C, Yilmazer A, Jackson MS, Humphreys NE, Kostarelos K. Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells. Biomaterials. 35: 8312-20. PMID 25002261 DOI: 10.1016/J.Biomaterials.2014.05.086  0.54
2014 de Lázaro I, Yilmazer A, Kostarelos K. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics? Journal of Controlled Release : Official Journal of the Controlled Release Society. 185: 37-44. PMID 24746625 DOI: 10.1016/J.Jconrel.2014.04.011  0.53
2013 Yilmazer A, de Lázaro I, Bussy C, Kostarelos K. In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors. Journal of Visualized Experiments : Jove. e50837. PMID 24378537 DOI: 10.3791/50837  0.565
2013 Yilmazer A, de Lázaro I, Bussy C, Kostarelos K. In vivo cell reprogramming towards pluripotency by virus-free overexpression of defined factors. Plos One. 8: e54754. PMID 23355895 DOI: 10.1371/Journal.Pone.0054754  0.53
2013 Yilmazer A, Al-Jamal WT, Van den Bossche J, Kostarelos K. The effect of artificial lipid envelopment of Adenovirus 5 (Ad5) on liver de-targeting and hepatotoxicity. Biomaterials. 34: 1354-63. PMID 23146432 DOI: 10.1016/J.Biomaterials.2012.10.053  0.693
2011 Van den Bossche J, Al-Jamal WT, Yilmazer A, Bizzarri E, Tian B, Kostarelos K. Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo. Biomaterials. 32: 3085-93. PMID 21269689 DOI: 10.1016/J.Biomaterials.2010.12.043  0.689
2010 Al-Jamal KT, Toma FM, Yilmazer A, Ali-Boucetta H, Nunes A, Herrero MA, Tian B, Eddaoudi A, Eddaoui A, Al-Jamal WT, Bianco A, Prato M, Kostarelo K. Enhanced cellular internalization and gene silencing with a series of cationic dendron-multiwalled carbon nanotube:siRNA complexes. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 4354-65. PMID 20647548 DOI: 10.1096/Fj.09-141036  0.695
2010 Al-Jamal KT, Al-Jamal WT, Akerman S, Podesta JE, Yilmazer A, Turton JA, Bianco A, Vargesson N, Kanthou C, Florence AT, Tozer GM, Kostarelos K. Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth Proceedings of the National Academy of Sciences of the United States of America. 107: 3966-3971. PMID 20150514 DOI: 10.1073/Pnas.0908401107  0.666
2010 Van den Bossche J, Al-Jamal WT, Yilmazer A, Kostarelos K. Efficient gene delivery using acid-responsive lipid envelopes for adenovirus Drug Discovery Today. 15: 1089-1089. DOI: 10.1016/J.Drudis.2010.09.378  0.679
Show low-probability matches.